Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.

[1]  G. McDonald,et al.  Gastrointestinal and Hepatic Complications , 2007 .

[2]  J. Klein,et al.  Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. , 2005, Blood.

[3]  W. Au,et al.  Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation , 2004, Bone Marrow Transplantation.

[4]  G. Morgan.  Thomas’ Hematopoietic Stem Cell Transplantation , 2004 .

[5]  W. Au,et al.  HEPATITIC GRAFT-VERSUS-HOST DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: CLINICOPATHOLOGIC FEATURES AND PROGNOSTIC IMPLICATION , 2004, Transplantation.

[6]  A. Dhillon,et al.  Graft-versus-host disease of the liver: 109 cases from a single-centre , 2004 .

[7]  M. Torbenson,et al.  Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. , 2002, Blood.

[8]  K. Takenaka,et al.  Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation , 2001, Bone Marrow Transplantation.

[9]  M. Flowers,et al.  Chronic graft‐versus‐host disease of the liver: Presentation as an acute hepatitis , 2000, Hepatology.

[10]  A. Dhillon,et al.  Development of ductopaenic liver allograft rejection includes a "hepatitic" phase prior to duct loss. , 2000, Journal of hepatology.

[11]  J. V. Stone,et al.  Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation , 1999 .

[12]  直子 加藤,et al.  Graft-Versus-host Disease , 1999 .

[13]  S. Hubscher.  Pathology of the Liver , 1996 .

[14]  M. Michallet.  Graft-versus-host disease and graft-versus-leukemia. , 1996, Hematology and cell therapy.

[15]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[16]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[17]  A. Dhillon,et al.  Grading of cellular rejection after orthotopic liver transplantation , 1995, Hepatology.

[18]  D. Weisdorf,et al.  Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation. , 1994, Transplantation.

[19]  H. Deeg,et al.  Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. , 1992, Blood.

[20]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[21]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[22]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[23]  J. Mary,et al.  Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. , 2004, Blood.

[24]  E. Brunt.  Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.

[25]  P. Scheuer,et al.  Liver Biopsy Interpretation , 1973 .